首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention

【24h】

Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention

机译：急性冠脉综合征或经皮冠状动脉介入治疗后双重抗血小板治疗的个体化持续时间

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Circulation: An Official Journal of the American Heart Association》 |2016年第21期|共5页
作者
Bagai Akshay; Bhatt Deepak L.; Eikelboom John W.; Mancini G. B. John; Cohen Eric A.; Vijayaraghavan Ram; Cheema Asim N.; Udell Jacob A.; Niznick Joel; Tanguay Jean-Francois; Verma Subodh; Mehta Shamir R.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Safety of 6-month duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndromes: Rationale and design of the Smart Angioplasty Research Team-safety of 6-month duration of Dual Antiplatelet Therapy after percutaneous coronary intervention in patients with acute coronary syndromes ( SMART-DATE) prospective multicenter randomized trial [J] . Lee Joo Myung, Cho Deok-Kyu, Hahn Joo-Yong, The American heart journal . 2016,第期

机译：急性冠状动脉综合征患者经皮冠状动脉干预后6个月持续时间持续时间：理论与设计急性冠状动脉患者急性冠状动脉经皮冠状动脉介入后6个月持续时间急性血管成形术研究团队 - 安全性综合征（智能日期）预期多中心随机试验
2. Response by Bagai et al to Letter Regarding Article, "Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention" [J] . Bagai Akshay, Bhatt Deepak L., Verma Subodh, Circulation: An Official Journal of the American Heart Association . 2016,第15期

机译：Bagai等对有关“急性冠脉综合征或经皮冠状动脉介入治疗后双重抗血小板治疗的个体化持续时间”的信函的答复
3. Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention [J] . Bagai Akshay, Bhatt Deepak L., Eikelboom John W., Circulation: An Official Journal of the American Heart Association . 2016,第21期

机译：急性冠脉综合征或经皮冠状动脉介入治疗后双重抗血小板治疗的个体化持续时间
4. Outcomes of Medical and Interventional Therapy in Elderly Patients with Acute Coronary Syndromes [C] . D.A. Halon, I. Dobrecky-Mery, S. Adawi, International Congress on Coronary Artery Disease . 2003

机译：老年急性冠状动脉综合征的老年患者的医疗和介入治疗结果
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention or after acute coronary syndrome [O] . J. M. ten Berg, B. Zwart, A. W. J. van ’t Hof, 2017

机译：经皮冠状动脉介入治疗或急性冠脉综合征后双重抗血小板治疗的最佳持续时间
7. Letter by Petrie Regarding Article, “Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention” [O] . Colin James Petrie 2016

机译：Petrie关于文章的信，“急性冠状动脉综合征或经皮冠状动脉干预后的双抗血小板治疗的个性化持续时间

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号